Z160: Completed Phase IIa enrollment

Zalicus completed enrollment of about 140 patients with lumbosacral radiculopathy in a double-blind, placebo-controlled, U.S. Phase IIa trial to evaluate

Read the full 208 word article

How to gain access

Continue reading with a
two-week free trial.